The Medicare end-stage renal disease program. A report from the Institute of Medicine.
Levinsky
N G
NG
Institute of Medicine Study Committee, Boston University Medical Center, MA 02118.
Rettig
R A
RA
D001741:Black or African American / Q000706:statistics & numerical data; D014487:Centers for Medicare and Medicaid Services, U.S.; D006297:Health Services Accessibility / Q000639:trends; D006436:Hemodialysis Units, Hospital / Q000639:trends; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007676:Kidney Failure, Chronic / Q000191:economics / Q000628:therapy*; D016030:Kidney Transplantation / Q000191:economics / Q000706:statistics & numerical data; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence*; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D015397:Program Evaluation; D011785:Quality Assurance, Health Care / Q000639:trends; D011787:Quality of Health Care / Q000639:trends; D006435:Renal Dialysis / Q000191:economics / Q000706:statistics & numerical data; D014481:United States; D044465:White People / Q000706:statistics & numerical data